Login to Your Account


End 'p' value devotion, randomized control phase III trial designs

By Nuala Moran
Staff Writer

Tuesday, June 16, 2015
LONDON – It is time to end the devotion to 'p' values and the randomized control phase III study, and to give greater weight to novel trial designs that draw on real world observational data and take an inductive approach to probability.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription